Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Is fear an effective driver of behaviour change?

White Papers and Resources | February 1, 2017 | Blue Latitude Health

Client Lead Natalie Seebeck explains that applying fear-based models in communications can be effective, if the right components are used in the right way.

PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

Press Releases | January 31, 2017 | Inizio

Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed...

2017 Trends Reports

White Papers and Resources | January 27, 2017 | Syneos Health®

GSW and InVentiv Health Communications are pleased to release the 6th installment of the Trends report series, consisting of four reports: Consumer, Digital, Communications and Healthcare

Smart connections with a human touch

White Papers and Resources | January 26, 2017 | Blue Latitude Health

Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support...

AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

White Papers and Resources | January 25, 2017 | Syneos Health®

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care.

Mental Health Patient Advocacy Groups in EU Say Strong Partnerships with Government and Industry Can Ensure Forward Progress

Press Releases | January 25, 2017 | Syneos Health®

New Report from inVentiv Health Examines Mental Health Advocacy Wish Lists and Priorities for Reform

Cool heads in a crisis?

White Papers and Resources | January 25, 2017 | Inizio

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

White Papers and Resources | January 25, 2017 | Inizio

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

White Papers and Resources | January 25, 2017 | Inizio

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London